Saglam Omer Faruk, Kilic Burcu, Ekinci Fidan Merve, Sayilgan Nevzat Cem, Kara H Volkan, Turna Akif, Kaynak Kamil, Ersen Ezel
Department of Thoracic Surgery, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Türkiye.
Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.
Front Surg. 2025 Jul 17;12:1635663. doi: 10.3389/fsurg.2025.1635663. eCollection 2025.
Awake video-assisted thoracoscopic surgery (A-VATS) has gained increasing attention as an alternative to classical intubated VATS (I-VATS), particularly in patients with comorbidities that have increased the risk of surgery under general anesthesia. This study aimed to compare the perioperative and postoperative outcomes of patients who underwent A-VATS vs. I-VATS for pleural diseases.
This is a retrospective cohort study including patients who underwent A-VATS ( = 22) and I-VATS ( = 37) for pleural diseases between July 2015 and March 2023 at a single tertiary step medical center. Patients considered unsuitable or at high risk for I-VATS due to anesthetic risk or comorbidities were allocated to the A-VATS group. Demographic characteristics, comorbidities, risk scores, spirometry results, surgical outcomes, anesthesia satisfaction, surgical and other complications, and laboratory parameters were analyzed.
A-VATS had significantly lower NRS scores at all postoperative timepoints (1, 12, 48 h; < 0.01) and reduced NSAID use ( = 0.04), whereas opioid use was similar between the groups. The incidence of postoperative atelectasis was higher in the I-VATS group ( < 0.001). Earlier oral intake, mobilization, and return of bowel function were observed in the A-VATS group (all values compared were < 0.001). Although the hospital stay was longer in the A-VATS group (5.0 vs. 2.0 days; = 0.01), there was no difference in hospitalization costs between the groups ( > 0.05). There was no difference in the overall complication rates ( > 0.05). Hematological and biochemical parameter changes were similar between the groups.
A-VATS is a potential feasible alternative in appropriate patients who have a higher risk with I-VATS. A-VATS offers favorable outcomes in terms of postoperative pain control and better recovery so may replace I-VATS. However, its use requires careful patient selection and perioperative planning due to the occurrence of severe complications in some cases. Prospective randomized, patient matched larger and multiple study groups are needed and in our future plan to confirm these findings and optimize the perioperative and postoperative protocols for A-VATS.
清醒电视辅助胸腔镜手术(A-VATS)作为传统插管式胸腔镜手术(I-VATS)的替代方法,越来越受到关注,尤其是在合并症增加全身麻醉手术风险的患者中。本研究旨在比较接受A-VATS与I-VATS治疗胸膜疾病患者的围手术期和术后结果。
这是一项回顾性队列研究,纳入了2015年7月至2023年3月期间在一家三级医疗中心因胸膜疾病接受A-VATS(n = 22)和I-VATS(n = 37)的患者。因麻醉风险或合并症被认为不适合或I-VATS风险高的患者被分配到A-VATS组。分析了人口统计学特征、合并症、风险评分、肺功能检查结果、手术结果、麻醉满意度、手术及其他并发症以及实验室参数。
A-VATS在所有术后时间点(1、12、48小时)的数字评分量表(NRS)得分显著更低(P < 0.01),非甾体抗炎药使用减少(P = 0.04),而两组间阿片类药物使用相似。I-VATS组术后肺不张发生率更高(P < 0.001)。A-VATS组观察到更早的经口进食、活动和肠功能恢复(所有比较值P < 0.001)。虽然A-VATS组住院时间更长(5.0天对2.0天;P = 0.01),但两组间住院费用无差异(P > 0.05)。总体并发症发生率无差异(P > 0.05)。两组间血液学和生化参数变化相似。
对于I-VATS风险较高的合适患者,A-VATS是一种潜在可行的替代方法。A-VATS在术后疼痛控制和更好恢复方面提供了良好的结果,因此可能取代I-VATS。然而,由于某些情况下会发生严重并发症,其使用需要仔细的患者选择和围手术期规划。需要前瞻性随机、患者匹配的更大规模和多个研究组,这也是我们未来计划的一部分,以证实这些发现并优化A-VATS的围手术期和术后方案。